Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes

NCT02372955 is registered in ClinicalTrials.gov with Gulf Regional Research & Educational Services, LLC as lead sponsor.

NCT NCT02372955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02372955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
Lead sponsor
Gulf Regional Research & Educational Services, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2016
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2